Clinical Trials · NCT00582556
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Wisconsin, Madison
- Enrollment
- 44
- Start date
- Apr 2003
- Locations
- 1 site, United States
- Primary endpoint
- The Number of Subjects Who Had Either an Increase or Decrease on Bone Mineral Density of the Lumbar Spine and Femoral Neck in Men Undergoing Androgen Deprivation Therapy for Prostate Adenocarcinoma.